These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 772653

  • 1. Xanthinol nicotinate in peripheral vascular disease.
    Davis E, Rozov H.
    Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
    [Abstract] [Full Text] [Related]

  • 2. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
    Mensen H.
    Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880
    [No Abstract] [Full Text] [Related]

  • 3. Thermographical follow-up during treatment of chronic ulcerations with iontophoresis with xanthinol nicotinate.
    van der Kuy A, Aarts NJ.
    Bibl Radiol; 1975 Oct; (6):203-9. PubMed ID: 1180851
    [No Abstract] [Full Text] [Related]

  • 4. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW, Buscher G, Dierdorf D, Freytag A, Mügge H, Wolf D.
    Arzneimittelforschung; 1985 Oct; 35(9):1468-72. PubMed ID: 4084347
    [Abstract] [Full Text] [Related]

  • 5. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G, Dupont T.
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE.
    Med Welt; 1973 Jan 19; 24(3):103-13. PubMed ID: 4617835
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies.
    Afifi AM, Adnan M, Taha M, Amasha ME.
    Curr Med Res Opin; 1979 Jan 19; 6(5):309-13. PubMed ID: 540521
    [Abstract] [Full Text] [Related]

  • 11. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II, Kukes VG, Borisov VG, Rudakov MA, Blistanova LS.
    Ter Arkh; 1977 Jan 19; 49(1):30-3. PubMed ID: 867235
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
    Baumann J, Martschick R.
    Med Welt; 1982 Jan 29; 33(4):139-41. PubMed ID: 7062844
    [No Abstract] [Full Text] [Related]

  • 13. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D, Cameli AM, Trapani M, Dorigo D, Mazzotta A, Negro P.
    Clin Ter; 1987 Jun 30; 121(6):479-83. PubMed ID: 2973884
    [No Abstract] [Full Text] [Related]

  • 14. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD.
    Med Monatsschr; 1976 Apr 30; 30(4):178-80. PubMed ID: 958145
    [No Abstract] [Full Text] [Related]

  • 15. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G, Majorana M.
    Clin Ter; 1983 Mar 15; 104(5):375-81. PubMed ID: 6303677
    [No Abstract] [Full Text] [Related]

  • 16. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G, Fabbri F, Benvenuti C.
    Clin Ter; 1983 Feb 28; 104(4):297-304. PubMed ID: 6861465
    [No Abstract] [Full Text] [Related]

  • 17. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE, Kessel ME.
    Z Allgemeinmed; 1975 Sep 20; (26):1167-72. PubMed ID: 1226797
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of complamin on the systemic and cerebral hemodynamics of atherosclerosis patients with chronic cerebral vascular disorders].
    Ishchenko MM, Dorogiĭ AN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Sep 20; 85(1):59-65. PubMed ID: 3984595
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D, Rojas Hidalgo E.
    Rev Clin Esp; 1988 Jan 20; 182(1):3-6. PubMed ID: 3375512
    [No Abstract] [Full Text] [Related]

  • 20. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K, Djaja S, Richter E.
    Ther Ggw; 1982 May 20; 121(5):301-11. PubMed ID: 6953613
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.